Skip to main content
Clinical Trials/NCT06548321
NCT06548321
Active, not recruiting
Not Applicable

Benefits of Extracorporeal Shockwave Therapy to Reduce Spasticity in Stroke/CP

Superior University1 site in 1 country28 target enrollmentOctober 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke, Cerebral
Sponsor
Superior University
Enrollment
28
Locations
1
Primary Endpoint
Modified Ashworth Scale MAS
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

This Study will help to explain us that ExtracorporealShockwave therapy can reduce spasticity in Stroke Patient,help them to restore their abilities and ROM.Therapy reduces dependency rate of patient.Also seen this therapy shows reduction in spasticity of CP child population.Improving the motor recovery.

Detailed Description

ESWT therapy increses molecular and immunological reactions,increase blood microcirculation and neurovascularization.It enhancing the neural proliferation of neural stem cell(NSC),which shows repair in brain function in CNS diseases.Extracorporeal shockwave can produce Nitric oxide in enzymatic and non enzymatic way which help, to reduce muscle spasm.Extracorporeal Shockwave reduce the exitibilty of motor neuron by vibratory stimulation of tendon and reduces tension.After 2 weeks ESWT muscle tension reduces increases range of motion reduces the pain.shock wave therapy appears to be effective in reducing spasticity levels irrespective of the age of the participants, the type of injury, and the tool used to measure the effect.ESWT change in motor neuron exitibilty \& also associated with the spastic muscle.

Registry
clinicaltrials.gov
Start Date
October 1, 2023
End Date
September 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Muhammad Naveed Babur

Principal Investigator

Superior University

Eligibility Criteria

Inclusion Criteria

  • 3rd stage of Stroke

Exclusion Criteria

  • Non spastic CP,1st stage of Stroke,Spasticity caused by injury,Newborn

Outcomes

Primary Outcomes

Modified Ashworth Scale MAS

Time Frame: 12 Months

The Ashworth Scale method of grading spasticity, working with Cerebral Palsy and Stroke patients. The original Ashworth scale was a 5 point numerical scale that graded spasticity from 0 to 4, with 0 being no resistance and 4 being a limb rigid in flexion or extension. In 1987, while performing a study to exam interrater reliability of manual tests of elbow flexor muscle spasticity, Bohannon and Smith modified the Ashworth scale by adding 1+ to the scale to increase sensitivity. Since its modification, the modified Ashworth scale (MAS), has been applied in clinical practice and research as a measure of spasticity.

Study Sites (1)

Loading locations...

Similar Trials